Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohortKLIFA, Catherine; CARBALLIDO-GAMIO, Julio; WILMES, Lisa et al.Magnetic resonance imaging. 2010, Vol 28, Num 1, pp 8-15, issn 0730-725X, 8 p.Article

Collective memory, candidacy, and victimisation : community epidemiologies of breast cancer riskSALANT, Talya; GEHLERT, Sarah.Sociology of health & illness (Print). 2008, Vol 30, Num 4, pp 599-615, issn 0141-9889, 17 p.Article

Mutations in the mitochondrial DNA D-loop region and breast cancer riskCHUANZHONG YE; XIAO OU SHU; PIERCE, Larry et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 431-436, issn 0167-6806, 6 p.Article

Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical dataSEEGER, Harald; MUECK, Alfred O.Journal of steroid biochemistry and molecular biology. 2008, Vol 109, Num 1-2, pp 11-15, issn 0960-0760, 5 p.Article

Ductal lavage in the high-risk patientFRANCESCATTI, Darius S; KLUSKENS, Larry; SHAH, Lisa et al.The American journal of surgery. 2005, Vol 189, Num 3, pp 340-341, issn 0002-9610, 2 p.Conference Paper

Fat/fiber intakes and sex hormones in healthy premenopausal women in USAAUBERTIN-LEHEUDRE, Mylène; GORBACH, Sherwood; WOODS, Margo et al.Journal of steroid biochemistry and molecular biology. 2008, Vol 112, Num 1-3, pp 32-39, issn 0960-0760, 8 p.Article

Exogenous progestagens and the human breastSITRUK-WARE, Regine; PLU-BUREAU, Genevieve.Maturitas (Amsterdam). 2004, Vol 49, Num 1, pp 58-66, issn 0378-5122, 9 p.Conference Paper

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive familiesKORDE, Larissa A; MUELLER, Christine M; LOUD, Jennifer T et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 169-173, issn 0167-6806, 5 p.Article

E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer StudyBEEGHLY-FADIEL, Alicia; WEI LU; GAO, Yu-Tang et al.Breast cancer research and treatment. 2010, Vol 121, Num 2, pp 445-452, issn 0167-6806, 8 p.Article

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjectsLEI YAO; FANG FANG; QI WU et al.Breast cancer research and treatment. 2010, Vol 122, Num 1, pp 221-227, issn 0167-6806, 7 p.Article

Prolactin and Breast Cancer Etiology : An Epidemiologic PerspectiveTWOROGER, Shelley S; HANKINSON, Susan E.Journal of mammary gland biology and neoplasia. 2008, Vol 13, Num 1, pp 41-53, issn 1083-3021, 13 p.Article

Why a consensus conference on hormone replacement therapy and the cardiovascular system?BENAGIANO, G; FARRIS, M.Maturitas (Amsterdam). 2004, Vol 47, Num 4, pp 245-253, issn 0378-5122, 9 p.Conference Paper

Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 yearsCANCER, Breast; REGISTRY, Family; CUNINGHAM, Kathleen et al.Breast cancer research and treatment. 2008, Vol 109, Num 1, pp 67-75, issn 0167-6806, 9 p.Article

Physical activity and mammographic breast density: a systematic reviewYAGHJYAN, Lusine; COLDITZ, Graham A; WOLIN, Kathleen et al.Breast cancer research and treatment. 2012, Vol 135, Num 2, pp 367-380, issn 0167-6806, 14 p.Article

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriersCATUCCI, Irene; VERDERIO, Paolo; VIEL, Alessandra et al.Breast cancer research and treatment. 2011, Vol 125, Num 3, pp 855-860, issn 0167-6806, 6 p.Article

No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer riskANDONOVA, Irena E; JUSTENHOVEN, Christina; KO, Yon-Dschun et al.Breast cancer research and treatment. 2010, Vol 121, Num 2, pp 497-502, issn 0167-6806, 6 p.Article

Recent developments in the ability to predict and modify breast cancer riskPRADO, Arturo; ANDRADES, Patricio; PARADA, Francisco et al.Journal of plastic, reconstructive & aesthetic surgery. 2010, Vol 63, Num 10, pp 1581-1587, issn 1748-6815, 7 p.Article

Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?BERNHOLTZ, Shiri; LAITMAN, Yael; KAUFMAN, Bella et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 669-673, issn 0167-6806, 5 p.Article

Germline mutations in RAD51C in Jewish high cancer risk familiesKUSHNIR, Anya; LAITMAN, Yael; PALUCH SHIMON, Shani et al.Breast cancer research and treatment. 2012, Vol 136, Num 3, pp 869-874, issn 0167-6806, 6 p.Article

The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysisZHOU, Wen-Bin; XUE, Dan-Qing; LIU, Xiao-An et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 7, pp 1053-1060, issn 0171-5216, 8 p.Article

Population-based estimates of the relation between breast cancer risk, tumor subtype, and family historyWELSH, Megan L; BUIST, Diana S. M; AIELLO BOWLES, Erin J et al.Breast cancer research and treatment. 2009, Vol 114, Num 3, pp 549-558, issn 0167-6806, 10 p.Article

Hormone replacement therapy and the risk of breast cancerCUZICK, Jack.European journal of cancer (1990). 2008, Vol 44, Num 16, pp 2344-2349, issn 0959-8049, 6 p.Article

Fruits, vegetables, soy foods and breast cancer in pre-and postmenopausal Korean women : A case-control studyMIN HEE DO; SANG SUN LEE; JUNG YUN KIM et al.International journal for vitamin and nutrition research. 2007, Vol 77, Num 2, pp 130-141, issn 0300-9831, 12 p.Article

Semi-automated and fully automated mammographic density measurement and breast cancer risk predictionLLOBET, Rafael; POLLAN, Marina; ANTON, Joaquín et al.Computer methods and programs in biomedicine (Print). 2014, Vol 116, Num 2, pp 105-115, issn 0169-2607, 11 p.Article

Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysisDAE SIK YANG; KYONG HWA PARK; OK HEE WOO et al.Breast cancer research and treatment. 2011, Vol 125, Num 3, pp 849-853, issn 0167-6806, 5 p.Article